Showing results (2861-2870 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|March 24, 2009
Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteersGopal Krishna, Allen Moton, Lei Ma, et al.Clinical Therapeutics|March 24, 2009
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational studyEli N Deal, Scott T Micek, Richard M Reichley, et al.Clinical Therapeutics|March 24, 2009
Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX) in a randomized, open-label, controlled study: an a priori subgroup analysisAd Jansen, Kristian Funding Andersen, Harald BrüningClinical Therapeutics|June 23, 2009
Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trialSang-Hyun Kim, Woo-Young Chung, Joo-Hee Zo, et al.Clinical Therapeutics|June 23, 2009
N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic coughPriscila Gebrim Louly, Patrícia Medeiros-Souza, Leopoldo Santos-NetoClinical Therapeutics|June 23, 2009
Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover studySang-Heon Cho, Hyeong-Seok Lim, Jong-Lyul Ghim, et al.Clinical Therapeutics|June 23, 2009
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpuraFeng Xie, Gord Blackhouse, Nazila Assasi, et al.Clinical Therapeutics|January 27, 2009
Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjectsHerbert R Henney, Anthony Fitzpatrick, Johnston Stewart, et al.Clinical Therapeutics|January 27, 2009
A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unitGretchen M Brophy, Valerie Sheehan, Marc J Shapiro, et al.Clinical Therapeutics|January 27, 2009
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trialAndrew J Lewin, Matthew R WeirPageof 678